As a result of a number of medical treatments, whilst rare, there are some that are at “increased risk” of developing CJD. The treatments include contact with:
- Pituitary Hormones
- Dura Mater grafts
- Cornea grafts
- Neurosurgical instruments
As a result of a number of medical treatments, whilst rare, there are some that are at “increased risk” of developing CJD. The treatments include contact with:
4 weeks ago
4 weeks ago
Bridge To Brisbane | Queensland's Largest Fun Run
bridgetobrisbane.com.au
Join thousands of runners, walkers, and wheelers as we take over the Gateway Bridge on Sunday 13 September 2026 for an unforgettable morning.1 month ago
2026 Transurban Bridge to Brisbane | CJD Support Group Network
click.grassrootz.com
Get ready to RUN FOR FUN when Queensland’s biggest, brightest, and best-loved fun run returns for it’s 30th Birthday in 2026! The Transurban Bridge to Brisbane will welcome an estimated 40,000 peo...2 months ago
ION717 trial re-opens with 3rd dosing regimen
www.cureffi.org
Ionis Pharmaceuticals is adding a third dosing regimen to PrProfile, its Phase 1/2a trial in symptomatic prion disease.2 months ago
Clinical Trial Update for Prion Diseases, December 2024 – CJD Support Group Network Australia
www.cjdsupport.org.au
December 2024 December 30th, 2024 – Enrolment is now complete for the Ionis Phase 1/2a clinical trial of ION717 called PrProfile for symptomatic prion disease patients. Updates will be provided as t...© 2026 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy